According to Barcelona Clinic Liver Cancer, the recommended first-line treatment for patients with intermediate stage of hepatocellular carcinoma (HCC) is transarterial chemoembolization. Patients with intermediate stage of HCC represent 20% with a 2-year survival of approximately 50%. Nowadays, transarterial therapies have proved precious in the treatment of hepatic malignancies. During the last years, there were important developments in practiced transarterial therapies and their efficacy is still controversial. The purpose of this review is to discuss in further details these transarterial therapies that have been used to treat cases of HCC.

Chegai, F., Orlacchio, A., Merolla, S., Monti, S., Mannelli, L. (2015). Intermediate hepatocellular carcinoma: the role of transarterial therapy. HEPATIC ONCOLOGY, 2(4), 397-408 [10.2217/hep.15.32].

Intermediate hepatocellular carcinoma: the role of transarterial therapy

ORLACCHIO, ANTONIO;
2015

Abstract

According to Barcelona Clinic Liver Cancer, the recommended first-line treatment for patients with intermediate stage of hepatocellular carcinoma (HCC) is transarterial chemoembolization. Patients with intermediate stage of HCC represent 20% with a 2-year survival of approximately 50%. Nowadays, transarterial therapies have proved precious in the treatment of hepatic malignancies. During the last years, there were important developments in practiced transarterial therapies and their efficacy is still controversial. The purpose of this review is to discuss in further details these transarterial therapies that have been used to treat cases of HCC.
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/36 - Diagnostica per Immagini e Radioterapia
English
HCC; cyrrhosis; TACE
Chegai, F., Orlacchio, A., Merolla, S., Monti, S., Mannelli, L. (2015). Intermediate hepatocellular carcinoma: the role of transarterial therapy. HEPATIC ONCOLOGY, 2(4), 397-408 [10.2217/hep.15.32].
Chegai, F; Orlacchio, A; Merolla, S; Monti, S; Mannelli, L
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
04 intermediate hepatocellular carcinoma- the role of transarterial therapy.pdf

accesso aperto

Licenza: Copyright dell'editore
Dimensione 1.52 MB
Formato Adobe PDF
1.52 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/160246
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 8
social impact